Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer - Université Côte d'Azur Access content directly
Journal Articles Oncoscience Year : 2018

Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer

Dates and versions

hal-02526788 , version 1 (31-03-2020)

Identifiers

Cite

Laetitia Seguin, Chloe C. Feral. Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer. Oncoscience, 2018, pp.124. ⟨10.18632/oncoscience.416⟩. ⟨hal-02526788⟩
29 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More